Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pulse Biosciences CS
(NQ:
PLSE
)
7.820
-0.230 (-2.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pulse Biosciences CS
< Previous
1
2
3
4
Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 14, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 14, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm
February 13, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
PULSE ALERT: Bragar Eagel & Squire, P.C. is Investigating Pulse Biosciences, Inc. on Behalf of Pulse Stockholders and Encourages Investors to Contact the Firm
February 11, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 11, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation
February 10, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Notifies Pulse Biosciences, Inc. (PLSE) Investors of Investigation
February 09, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 08, 2022
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 08, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Pulse Biosciences, Inc. (PLSE) on Behalf of Investors
February 08, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
February 08, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 01, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
January 11, 2022
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Participate in the Stephens Annual Investment Conference
November 18, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Third Quarter 2021 Financial Results
November 15, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Present at the Stifel 2021 Virtual Healthcare Conference
November 04, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021
November 02, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors
October 05, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference
September 02, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer
August 19, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Second Quarter 2021 Financial Results
August 09, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules Second Quarter 2021 Financial Results Conference Call for August 9, 2021
July 26, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces $50 Million Private Placement
July 01, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces First CellFX® Procedure Performed in Canada
June 30, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Health Canada Approval for CellFX® System
June 09, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Participate in the Jefferies Healthcare Conference
May 24, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences® Presents Clinical Study Results of Nano-Pulse Stimulation™ Technology to Clear Benign Lesions at the American Society for Laser Medicine and Surgery (ASLMS) 2021 Virtual Annual Conference
May 13, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports First Quarter 2021 Financial Results
May 10, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules First Quarter 2021 Financial Results Conference Call for May 10, 2021
April 26, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences to Present Consumer Research on Patient Perceptions of Benign Lesion Clearance at American Academy of Dermatology VMX Meeting 2021
April 22, 2021
From
Pulse Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.